Condition: Liver Neoplasms · Sponsor: Boston Scientific Corporation
To investigate the safety and effectiveness of BSJ019T in Japanese patients with primary or secondary liver who are not candidate for standard treatment.
This description comes directly from the study's public registry record.
Satoru Motohashi · +81(80)4619-9640 · satoru.motohashi@bsci.com
Always discuss trial participation with your own doctor first.
| Hyogo College of Medicine Hospital | Nishinomiya, Hyōgo, Japan | Not Yet Recruiting |
| Kanazawa University Hospital | Kanazawa, Ishikawa-ken, Japan | Recruiting |
| Kindai University Hospital | Sayama, Osaka, Japan | Not Yet Recruiting |
| National Cancer Center Hospital | Chuo Ku, Tokyo, Japan | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07377487